Human T cells induce their own regulation through activation of B cells

Journal of Autoimmunity

Volumn 36, Issue 3-4, 2011, Pages 228-238

  Lemoine, Sébastien ^a,b   Morva, Ahsen ^a   Youinou, Pierre ^a,b   Jamin, Christophe ^a,b  

^a UNIVERSITÉ EUROPÉENNE DE BRETAGNE   (France)

^b BREST UNIVERSITY HOSPITAL   (France)

Author keywords

Autoimmune disease; IL 10; Regulatory B cells; Regulatory T cells; Systemic lupus erythematosus; T cell response

Indexed keywords

B7 ANTIGEN; CD19 ANTIGEN; CD24 ANTIGEN; CD38 ANTIGEN; CD40 ANTIGEN; CD5 ANTIGEN; CD86 ANTIGEN; CYTOKINE; IMMUNOGLOBULIN D; INTERLEUKIN 10; TRANSCRIPTION FACTOR FOXP3;

ARTICLE; AUTOIMMUNE DISEASE; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL DIFFERENTIATION; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REGULATORY T LYMPHOCYTE; SYSTEMIC LUPUS ERYTHEMATOSUS; T LYMPHOCYTE; TH1 CELL;

ANTIGENS, CD; ANTIGENS, CD40; ANTIGENS, CD80; B-LYMPHOCYTES; CD40 LIGAND; CELLS, CULTURED; HUMANS; INTERLEUKIN-10; LUPUS ERYTHEMATOSUS, SYSTEMIC; LYMPHOCYTE ACTIVATION; T-LYMPHOCYTES; T-LYMPHOCYTES, REGULATORY;

EID: 79954939552     PISSN: 08968411     EISSN: 10959157     Source Type: Journal    
DOI: 10.1016/j.jaut.2011.01.005     Document Type: Article

References (45)

1. Porakishvili N., Mageed R., Jamin C., Pers J.O., Kulikova N., Renaudineau Y., et al. Recent progress in the understanding of B-cell functions in autoimmunity. Scand J Immunol 2001, 54:30-38.
2. Isenberg D.A. B cell targeted therapies in autoimmune diseases. J Rheumatol Suppl 2006, 77:24-28.
3. Fillatreau S., Sweenie C.H., McGeachy M.J., Gray D., Anderton S.M. B cells regulate autoimmunity by provision of IL-10. Nat Immunol 2002, 3:944-950.
4. Mizoguchi A., Mizoguchi E., Smith R.N., Preffer F.I., Bhan A.K. Suppressive role of B cells in chronic colitis of T cell receptor alpha mutant mice. J Exp Med 1997, 186:1749-1756.
5. Mauri C., Gray D., Mushtaq N., Londei M. Prevention of arthritis by interleukin 10-producing B cells. J Exp Med 2003, 197:489-501.
6. Lemoine S., Morva A., Youinou P., Jamin C. Regulatory B cells in autoimmune diseases: how do they work?. Ann N Y Acad Sci 2009, 1173:260-267.
7. Mizoguchi A., Bhan A.K. A case for regulatory B cells. J Immunol 2006, 176:705-710.
8. Mauri C., Ehrenstein M.R. The 'short' history of regulatory B cells. Trends Immunol 2008, 29:34-40.
9. Bouaziz J.D., Yanaba K., Tedder T.F. Regulatory B cells as inhibitors of immune responses and inflammation. Immunol Rev 2008, 224:201-214.
10. Lenert P., Brummel R., Field E.H., Ashman R.F. TLR-9 activation of marginal zone B cells in lupus mice regulates immunity through increased IL-10 production. J Clin Immunol 2005, 25:29-40.
11. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007, 178:7868-7878.
12. Sun C.M., Deriaud E., Leclerc C., Lo-Man R. Upon TLR9 signaling, CD5 + B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs. Immunity 2005, 22:467-477.
13. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
14. Asadullah K., Sterry W., Volk H.D. Interleukin-10 therapy-review of a new approach. Pharmacol Rev 2003, 55:241-269.
15. Tian J., Zekzer D., Hanssen L., Lu Y., Olcott A., Kaufman D.L. Lipopolysaccharide-activated B cells down-regulate Th1 immunity and prevent autoimmune diabetes in nonobese diabetic mice. J Immunol 2001, 167:1081-1089.
16. Mann M.K., Maresz K., Shriver L.P., Tan Y., Dittel B.N. B cell regulation of CD4 + CD25 + T regulatory cells and IL-10 via B7 is essential for recovery from experimental autoimmune encephalomyelitis. J Immunol 2007, 178:3447-3456.
17. Wei B., McPherson M., Turovskaya O., Velazquez P., Fujiwara D., Brewer S., et al. Integration of B cells and CD8 + T in the protective regulation of systemic epithelial inflammation. Clin Immunol 2008, 127:303-312.
18. Wei B., Velazquez P., Turovskaya O., Spricher K., Aranda R., Kronenberg M., et al. Mesenteric B cells centrally inhibit CD4 + T cell colitis through interaction with regulatory T cell subsets. Proc Natl Acad Sci USA 2005, 102:2010-2015.
19. Tretter T., Venigalla R.K., Eckstein V., Saffrich R., Sertel S., Ho A.D., et al. Induction of CD4 + T-cell anergy and apoptosis by activated human B cells. Blood 2008, 112:4555-4564.
20. Blair P.A., Chavez-Rueda K.A., Evans J.G., Shlomchik M.J., Eddaoudi A., Isenberg D.A., et al. Selective targeting of B cells with agonistic anti-CD40 is an efficacious strategy for the generation of induced regulatory T2-like B cells and for the suppression of lupus in MRL/lpr mice. J Immunol 2009, 182:3492-3502.
21. Blair P.A., Noreña L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthyindividuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
22. Jamin C., Morva A., Lemoine S., Daridon C., de Mendoza A.R., Youinou P. Regulatory B lymphocytes in humans: a potential role in autoimmunity. Arthritis Rheum 2008, 58:1900-1906.
23. Goetz M., Atreya R., Ghalibafian M., Galle P.R., Neurath M.F. Exacerbation of ulcerative colitis after rituximab salvage therapy. Inflamm Bowel Dis 2007, 13:1365-1368.
24. Dass S., Vital E.M., Emery P. Development of psoriasis after B cell depletionwith rituximab. Arthritis Rheum 2007, 56:2715-2718.
25. Mizoguchi E., Mizoguchi A., Preffer F.I., Bhan A.K. Regulatory role of mature B cells in a murine model of inflammatory bowel disease. Int Immunol 2000, 12:597-605.
26. Lund F.E., Randall T.D. Effector and regulatory B cells: modulators of CD4(+) T cell immunity. Nat Rev Immunol 2010, 10:236-247.
27. Levings M.K., Gregori S., Tresoldi E., Cazzaniga S., Bonini C., Roncarolo M.G. Differentiation of Tr1 cells by immature dendritic cells requires IL-10 but not CD25 + CD4 + Tr cells. Blood 2005, 105:1162-1169.
28. Reichardt P., Dornbach B., Rong S., Beissert S., Gueler F., Loser K., et al. Naive B cells generate regulatory T cells in the presence of a mature immunologic synapse. Blood 2007, 110:1519-1529.
29. Bijl M., Horst G., Limburg P.C., Kallenberg C.G. Expression of costimulatory molecules on peripheral blood lymphocytes of patients with systemic lupus erythematosus. Ann Rheum Dis 2001, 60:523-526.
30. Nagafuchi H., Shimoyama Y., Kashiwakura J., Takeno M., Sakane T., Suzuki N. Preferential expression of B7.2 (CD86), but not B7.1 (CD80), on B cells induced by CD40/CD40L interaction is essential for anti-DNA autoantibody production in patients with systemic lupus erythematosus. Clin Exp Rheumatol 2003, 21:71-77.
31. O'Keefe T.L., Williams G.T., Batista F.D., Neuberger M.S. Deficiency in CD22, a B cell-specific inhibitory receptor, is sufficient to predispose to development of high affinity autoantibodies. J Exp Med 1999, 189:1307-1313.
32. Wilkinson R., Lyons A.B., Roberts D., Wong M.X., Bartley P.A., Jackson D.E. Platelet endothelial cell adhesion molecule-1 (PECAM-1/CD31) acts as a regulator of B-cell development, B-cell antigen receptor (BCR)-mediated activation, and autoimmune disease. Blood 2002, 100:184-193.
33. Nishimura H., Nose M., Hiai H., Minato N., Honjo T. Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999, 11:141-151.
34. Nakano S., Morimoto S., Suzuki J., Mitsuo A., Nakiri Y., Katagiri A., et al. Hashimoto H, Takasaki Y. Down-regulation of CD72 and increased surface IgG on B cells in patients with lupus nephritis. Autoimmunity 2007, 40:9-15.
35. Huck S., Le Corre R., Youinou P., Zouali M. Expression of B cell receptor-associated signaling molecules in human lupus. Autoimmunity 2001, 33:213-224.
36. Venigalla R.K., Tretter T., Krienke S., Max R., Eckstein V., Blank N., et al. Reduced CD4+, CD25- T cell sensitivity to the suppressive function of CD4+, CD25high, CD127 -/low regulatory T cells in patients with active systemic lupus erythematosus. Arthritis Rheum 2008, 58:2120-2130.
37. Vargas-Rojas M.I., Crispín J.C., Richaud-Patin Y., Alcocer-Varela J. Quantitative and qualitative normal regulatory T cells are not capable of inducing suppression in SLE patients due to T-cell resistance. Lupus 2008, 17:289-294.
38. Valencia X., Yarboro C., Illei G., Lipsky P.E. Deficient CD4 + CD25high T regulatory cell function in patients with active systemic lupus erythematosus. J Immunol 2007, 178:2579-2588.
39. Bonelli M., Savitskaya A., von Dalwigk K., Steiner C.W., Aletaha D., Smolen J.S., et al. Quantitative and qualitative deficiencies of regulatory T cells in patients with systemic lupus erythematosus (SLE). Int Immunol 2008, 20:861-868.
40. Watanabe R., Ishiura N., Nakashima H., Kuwano Y., Okochi H., Tamaki K., et al. Regulatory B cells (B10 cells) have a suppressive role in murine lupus: CD19 and B10 cell deficiency exacerbates systemic autoimmunity. J Immunol 2010, 184:4801-4809.
41. Duddy M.E., Alter A., Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?. J Immunol 2004, 172:3422-3427.
42. Garaud S., Le Dantec C., de Mendoza A.R., Mageed R.A., Youinou P., Renaudineau Y. IL-10 production by B cells expressing CD5 with the alternative exon 1B. Ann N Y Acad Sci 2009, 1173:280-285.
43. Matsushita T., Yanaba K., Bouaziz J.D., Fujimoto M., Tedder T.F. Regulatory B cells inhibit EAE initiation in mice while other B cells promote disease progression. J Clin Invest 2008, 118:3420-3430.
44. Takeda K., Kaisho T., Akira S. Toll-like receptors. Annu Rev Immunol 2003, 21:335-376.
45. Lampropoulou V., Hoehlig K., Roch T., Neves P., Calderón Gómez E., Sweenie C.H., et al. TLR-activated B cells suppress T cell-mediated autoimmunity. J Immunol 2008, 180:4763-4773.